Bayer Advances Toward Resolving Roundup Litigation
March 13 2020 - 3:01PM
Dow Jones News
By Laura Kisisto and Jacob Bunge
Bayer AG has agreed on draft settlement terms with half a dozen
law firms representing tens of thousands of plaintiffs alleging
that its Roundup weedkiller causes cancer, pushing the litigation
closer to a final resolution, according to people familiar with the
matter.
The six big firms speak on behalf of dozens of other firms that
represent a large chunk of the plaintiffs suing Bayer, the people
said. Bayer is striving to find a way to both keep Roundup on
consumer shelves and end litigation that significantly damaged its
share price following the loss of three jury trials.
For weeks, Bayer and plaintiffs attorneys have been discussing a
settlement in the $10 billion range, The Wall Street Journal has
reported, citing people familiar with the matter. One person said
the deal still appears poised to end up around that number.
But these people cautioned that a formal deal hasn't been signed
and could yet fall apart.
Parties on both sides are free to walk away from the agreements,
and Bayer has said that protecting itself from future litigation is
a condition of any settlement.
The parties could reach a final agreement in the coming weeks,
they said. That would help Bayer appease anxious shareholders in
advance of its annual meeting in late April. A first deal with
plaintiff lawyers would relieve the German chemicals and
pharmaceuticals company of a major headache as the company is under
growing pressure to reach a settlement to appease investors.
Kenneth Feinberg, the court-appointed mediator for the
settlement talks, said he continues to be "cautiously optimistic
that a settlement can be reached" but called it "premature" to say
any final agreement has been achieved.
A spokesman for Bayer said, "Mediation discussions continue in
good faith under a court order requiring confidentiality, and the
company cannot comment on speculation about outcomes, timing or
progress."
Tens of thousands of plaintiffs have sued Bayer, saying its
popular weedkiller is linked to cancer. The company has defended
the product, noting that multiple regulators, including the U.S.
Environmental Protection Agency, have said it is safe. The company
lost its first three jury trials, all of which it is appealing.
--.Ruth Bender contributed to this article.
Write to Jacob Bunge at jacob.bunge@wsj.com
(END) Dow Jones Newswires
March 13, 2020 14:46 ET (18:46 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bayer Aktiengesellschaft (PK) (USOTC:BAYRY)
Historical Stock Chart
From Sep 2023 to Sep 2024